Specialised Therapeutics Acquires Commercialisation Rights to New Oral MND Therapy Singapore and Tilburg, Netherlands, August 28 2023: Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) will partner ... Read More August 1, 2023 ...
Specialised Therapeutics Acquires Commercialisation Rights to New Oral MND Therapy Singapore and Tilburg, Netherlands, August 28 2023: Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) will partner ... Read More August 1, 2023 ...
关于Specialised Therapeutics Specialised Therapeutics Asia Pte Ltd(ST)是一家总部位于新加坡的全球化生物制药公司,旨在为澳大利亚、新西兰及东南亚的患者提供新的治疗方法与技术。ST 及其区域附属公司已与全球领先的制药和诊断公司合作,为受各种疾病影响的患者带来创新的医疗保健解决方案。针对未满足的临床需求提供治疗方法是...
SpecialisedTherapeuticsAsia Pte Ltd(ST)是一家总部位于新加坡的全球化生物制药公司,旨在为澳大利亚、新西兰及东南亚的患者提供新的治疗方法与技术。 ST 及其区域附属公司已与全球领先的制药和诊断公司合作,为受各种疾病影响的患者带来创新的医疗保健解决方案。针对未满足的临床需求提供治疗方法是公司发展使命。目前公司广泛的...
PharmaMar announced an agreement with Singapore-based Specialised Therapeutics Asia to market the marine-based anti-tumour compound of the company, lurbinectedin (PM1183) for the treatment of platinum-resistant ovarian cancer, small-cell lung cancer, BRCA 1/2 -assoc...